In the last trading session, 1.14 million shares of the InMed Pharmaceuticals Inc (NASDAQ:INM) were traded, and its beta was 0.73. Most recently the company’s share price was $0.29, and it changed around -$0.07 or -18.36% from the last close, which brings the market valuation of the company to $0.97M. INM currently trades at a discount to its 52-week high of $0.78, offering almost -168.97% off that amount. The share price’s 52-week low was $0.12, which indicates that the current value has risen by an impressive 58.62% since then. We note from InMed Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 1.89 million shares, with the 3-month average coming to 6.67 million.
InMed Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended INM as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. InMed Pharmaceuticals Inc is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
Instantly INM has showed a red trend with a performance of -18.36% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3580 on recent trading dayincreased the stock’s daily price by 18.99%. The company’s shares are currently down -30.29% year-to-date, but still down -9.09% over the last five days. On the other hand, InMed Pharmaceuticals Inc (NASDAQ:INM) is 22.36% up in the 30-day period. We can see from the shorts that 40007.0 shares have been sold at a short interest cover period of 0.15 day(s).
InMed Pharmaceuticals Inc (INM) estimates and forecasts
The year-over-year growth rate is expected to be 47.20%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 6.77M in revenue for the current quarter. Analysts predict that the company’s current quarter sales will jump, forecast at 47.20%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 53.87%.
INM Dividends
InMed Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in November.
InMed Pharmaceuticals Inc (NASDAQ:INM)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.62% of InMed Pharmaceuticals Inc shares, and 5.54% of them are in the hands of institutional investors. The stock currently has a share float of 5.58%. InMed Pharmaceuticals Inc stock is held by 14.0 institutions, with SABBY MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 3.1961% of the shares, which is about 0.31 million shares worth $81571.0.
VIRTU FINANCIAL LLC, with 0.9017% or 86684.0 shares worth $23000.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
